# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 4051 results.
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Status: Completed
Last Changed: Jun 28, 2017
First Received: Jan 17, 2011
Disease(s): Hepatitis C
Intervention(s): GSK2336805 10mg, GSK2336805 30mg, GSK2236805 100mg, GSK2236805 200mg, GSK2236805 10mg, GSK2236805 dose to be determined up to 100mg, GSK2236805 5mg, GSK2236805 30mg, GSK2236805 100mg
Locations: GSK Investigational Site, Chula Vista, California, United States
GSK Investigational Site, Lenexa, Kansas, United States
GSK Investigational Site, Willingboro, New Jersey, United States
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Status: Terminated
Last Changed: Mar 17, 2020
First Received: Feb 06, 2008
Disease(s): Autoimmune Hepatitis
Intervention(s): LCP-Tacro (tacrolimus), Azathioprine
Locations: Mayo Clinic - Phoenix, Phoenix, Arizona, United States
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Northwestern University, Chicago, Illinois, United States
University of Minnesota, Minneapolis, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
... and 8 other locations.
UHN Inpatient Hepatitis C & B Screening
Status: Not yet recruiting
Last Changed: Nov 06, 2020
First Received: Nov 06, 2020
Disease(s): Hepatitis C, Hepatitis B
Intervention(s): Quality Improvement
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
Status: Recruiting
Last Changed: Dec 17, 2019
First Received: Dec 06, 2019
Disease(s): Hepatitis B Virus (HBV)
Intervention(s): ETV/TDF+T101 No.1, ETV/TDF+T101 No.2, ETV or TDF, ETV/TDF+Peg-IFNα-2b
Locations: Beijing Youan Hospital,Capital Medical University, Beijing, Beijing, China
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
Status: Completed
Last Changed: Feb 04, 2013
First Received: Jan 28, 2013
Disease(s): Hepatitis B
Intervention(s): Data collection
Locations: GSK Investigational Site, Agde cedex, France
GSK Investigational Site, Agen cedex, France
GSK Investigational Site, Agen, France
GSK Investigational Site, Aire sur la lys, France
GSK Investigational Site, Aizenay, France
... and 398 other locations.
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients
Status: Completed
Last Changed: Dec 04, 2019
First Received: Nov 19, 2019
Disease(s): Hepatitis B Virus (HBV)
Intervention(s): T101 Group, Placebo Group
Locations: The First Hospital of Jilin University, Changchun, China
Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
Status: Completed
Last Changed: Feb 15, 2017
First Received: Jun 04, 2015
Disease(s): Autoimmune Hepatitis
Intervention(s): Chloroquine diphosphate, prednisone, azathioprine
Protective Immune Mechanisms in Alcoholic Hepatitis
Status: Recruiting
Last Changed: Feb 19, 2018
First Received: Aug 07, 2013
Disease(s): Alcoholic Hepatitis
Locations: Department of Hepatology and gastroenterology V, Aarhus university hospital, Aarhus, Denmark
Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative
Status: Unknown status
Last Changed: Dec 01, 2005
First Received: Sep 09, 2005
Disease(s): Hepatitis B
Locations: Liver Clinic, Toronto Western Hospital, UHN., Toronto, Ontario, Canada
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
Status: Completed
Last Changed: Oct 18, 2019
First Received: Jul 29, 2014
Disease(s): Hepatitis B
Intervention(s): Hepatitis B vaccine
Locations: Peking University, Beijing, China